In recent years, the biopharmaceutical industry has emerged as one of the most important sectors in the Healthcare industry. Advances in life sciences have resulted in the drug discovery process becoming more science-intensive, with an increasing emphasis cross-company collaborations and the exchange of information.

However, growing commercial pressures and rising R&D costs have prompted many biotech companies to seek financial support from global Big Pharma corporations through licensing and collaborative R&D deals. Progressive enhancements in integration have subsequently led to traditional pharma companies becoming increasingly dependant upon the technology platforms and approaches adopted by biotech companies.

The Fastest Growing Biopharmaceutical Companies: Growth strategies, comparative analysis and company profiles is a new report published by Business Insights that examines the structure and organization of the biopharmaceutical industry with a detailed analysis of the fastest growing biopharmaceutical companies. This report provides a comparative analysis of growth strategies and reviews the methods used to improve operational efficiency in light of cost pressures, generic competition, complex pricing, regulations, and globalization.

This report also explores the levels of interaction and integration between biopharma companies and the wider pharma industry. Use key indicators to assess the performances of the fastest growing biopharma companies, benchmark their most successful strategies and understand major industrial issues with this new report.